Silverarc Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

Silverarc Capital Management’s Portfolio APLS Stock Details APLS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$599K	Buy
2022 Q3	–	Sell
2022 Q2	$5.87M	Buy
2022 Q1	$5.35K	Buy
2021 Q3	–	Sell
2021 Q2	$443	Buy